Order Article Reprints

Walczuk S, Cunningham FE, Zhao X, Dong D, Glassman PA, Miller DR, Khachikian D, Au A, Salone C, Bryan K, et al. Treatment Patterns, Effectiveness, and Safety of Originator Insulin Glargine versus Insulin Glargine-yfgn within the Veterans Health Administration. Pharmacoepidemiology. 2024; 3(1):103-116. https://doi.org/10.3390/pharma3010008

Walczuk, Samantha, Francesca E. Cunningham, Xinhua Zhao, Diane Dong, Peter A. Glassman, Donald R. Miller, Deborah Khachikian, Anthony Au, Cedric Salone, Kelly Bryan, and et al. 2024. "Treatment Patterns, Effectiveness, and Safety of Originator Insulin Glargine versus Insulin Glargine-yfgn within the Veterans Health Administration" Pharmacoepidemiology 3, no. 1: 103-116. https://doi.org/10.3390/pharma3010008

Walczuk, S., Cunningham, F. E., Zhao, X., Dong, D., Glassman, P. A., Miller, D. R., Khachikian, D., Au, A., Salone, C., Bryan, K., Her, Q., & Aspinall, S. L. (2024). Treatment Patterns, Effectiveness, and Safety of Originator Insulin Glargine versus Insulin Glargine-yfgn within the Veterans Health Administration. Pharmacoepidemiology, 3(1), 103-116. https://doi.org/10.3390/pharma3010008